Skip to content
Search

Latest Stories

New tool to detect ‘heart risk’ early: The Times

Researchers have developed a new tool to identify people in danger of having a heart attack or stroke much earlier, according to a report in The Times.

The Score2 tool, which experts hailed as a ‘major advance’, is ready for use in the UK and Europe.


It allows doctors to predict who will have a heart attack or stroke in the next decade by combining data including a patient’s age, sex, blood pressure and cholesterol levels, the report said.

“This risk tool is much more powerful and superior to what doctors have used for decades. It will fit seamlessly into current prevention programmes with substantial real-world impact by improving the prevention of cardiovascular diseases across Europe,” Professor Emanuele Di Angelantonio, of the University of Cambridge, who led the research, told The Times.

“Once you are better able to predict the risk you can really discuss the benefits of starting a treatment early on, or making some behavioural changes. By providing a better tool, you’ll possibly be able to make better decisions.

“It could result in a higher number of people suggested to take statins but I think the main aim first of all, before going to treatment, is behavioural change — smoking, diet, lifestyle.”

Score2 replaces a risk calculator created 20 years ago. Unlike its predecessor it predicts someone’s chances of having any heart attack and stroke, not only fatal heart attacks and strokes.

According to experts, the tool is better at picking up risk at younger ages, in people aged between 40 and 60.

The new tool was created using data on nearly 700,000 people taking part in studies across Europe. During ten years of follow-up, 30,000 of them had a ‘cardiovascular event’, including fatal and non-fatal heart attacks and strokes, the report said.

Di Angelantonio said: “We know that for people living in (some countries) in eastern Europe, the risk of developing cardiovascular disease is much higher compared to other parts of Europe, for example in the UK. Reasons for the differences might include differences in lifestyle, average socioeconomic status or pollution levels.

“You really want to tailor your risk prediction to those different settings. Otherwise you can end up over-predicting in one group and under-predicting in the other; not identifying people in one country and finding too many in the other.”

According to the research, a 50-year-old man who smoked, had a systolic [the force at which the heart pumps blood] pressure of 140, total cholesterol of 5.5 and so-called good cholesterol of 1.3 had a 5.9 per cent risk of heart attack or stroke in low-risk countries but a 14 per cent risk in very high-risk countries.

For a woman of the same age the difference ranged from 4.2 per cent to 13.7 per cent.

The UK is considered a low-risk country for cardiovascular problems, after improvements in its death rates from heart attacks and stroke.

GPs in the UK already make similar calculations using a tool known as Qrisk. Di Angelantonio said that it would be up to policymakers whether to recommend Score2.

Dr Lisa Pennells, a researcher at the University of Cambridge British Heart Foundation Centre of Research Excellence, told The Times: “This project was a highly collaborative effort. A key feature is that our calculators are relevant to current day rates of cardiovascular disease in different regions of Europe. Importantly, our methods allow them to be easily updated using routinely collected data in the future to ensure they stay relevant as trends in heart and circulatory diseases change.”

Professor Sir Nilesh Samani, medical director at the British Heart Foundation has said that the new risk tool will be the new gold standard for doctors.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less